search icon
tenx-img

Tenax Therapeutics Inc, Common Stock

TENX

NAQ

$6.15

+$0.08

(1.32%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$25.51M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
3.5706
Volume info-icon
This is the total number of shares traded during the most recent trading day.
6.05K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.91
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$2.77 L
$7.89 H
$6.15

About Tenax Therapeutics Inc, Common Stock

Tenax Therapeutics, Inc., a clinical-stage pharmaceutical company, develops novel cardiopulmonary therapies in the United States. It develops TNX-101, TNX-102, and TNX-103 (levosimendan) that have completed phase II clinical trials for the treatment of patients with pulmonary hypertension in heart failure with preserved ejection fraction and associated pulmonary hypertension; and TNX-201 (imatinib), a tyrosine kinase inhibitor for the treatment of chronic myeloid leukemia. The company was formerly known as Oxygen Biotherapeutics, Inc. and changed its name to Tenax Therapeutics, Inc. in September 2014. Tenax Therapeutics, Inc. was founded in 1967 and is based in Chapel Hill, North Carolina. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameTENXSectorS&P500
1-Week Return-0.71%0.79%
1-Month Return8.56%-5.6%6.04%
3-Month Return3.02%-11.72%-1.11%
6-Month Return14.74%-10.81%-2.39%
1-Year Return73.97%-7.12%11.69%
3-Year Return-99.42%-0.57%42.29%
5-Year Return-99.73%27.64%93.12%
10-Year Return-99.99%75.45%179.21%

Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue114.75K108.98K113.33K7.57K-[{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":94.98,"profit":true},{"date":"2022-12-31","value":98.77,"profit":true},{"date":"2023-12-31","value":6.6,"profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Gross Profit(114.75K)(108.98K)(113.33K)(7.57K)-[{"date":"2020-12-31","value":-11474800,"profit":false},{"date":"2021-12-31","value":-10898200,"profit":false},{"date":"2022-12-31","value":-11333200,"profit":false},{"date":"2023-12-31","value":-757000,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses9.87M32.73M11.05M8.23M19.49M[{"date":"2020-12-31","value":30.15,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":33.77,"profit":true},{"date":"2023-12-31","value":25.16,"profit":true},{"date":"2024-12-31","value":59.56,"profit":true}]
Operating Income(9.87M)(32.73M)(11.05M)(8.23M)(19.49M)[{"date":"2020-12-31","value":-986793000,"profit":false},{"date":"2021-12-31","value":-3272824100,"profit":false},{"date":"2022-12-31","value":-1105264300,"profit":false},{"date":"2023-12-31","value":-823394100,"profit":false},{"date":"2024-12-31","value":-1949400000,"profit":false}]
Total Non-Operating Income/Expense14.91K252.93K305.00868.33K3.78M[{"date":"2020-12-31","value":0.39,"profit":true},{"date":"2021-12-31","value":6.69,"profit":true},{"date":"2022-12-31","value":0.01,"profit":true},{"date":"2023-12-31","value":22.95,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(9.85M)(32.47M)(11.05M)(7.71M)(17.60M)[{"date":"2020-12-31","value":-985139100,"profit":false},{"date":"2021-12-31","value":-3247435800,"profit":false},{"date":"2022-12-31","value":-1104789500,"profit":false},{"date":"2023-12-31","value":-771067300,"profit":false},{"date":"2024-12-31","value":-1760200000,"profit":false}]
Income Taxes19.79K255.78K(4.75K)1.00-[{"date":"2020-12-31","value":7.74,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-1.86,"profit":false},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Income After Taxes(9.87M)(32.73M)(11.04M)(7.71M)-[{"date":"2020-12-31","value":-987118400,"profit":false},{"date":"2021-12-31","value":-3273013900,"profit":false},{"date":"2022-12-31","value":-1104314700,"profit":false},{"date":"2023-12-31","value":-771067400,"profit":false},{"date":"2024-12-31","value":"-","profit":true}]
Income From Continuous Operations(9.85M)(32.47M)(11.05M)(7.03M)(17.60M)[{"date":"2020-12-31","value":-985139100,"profit":false},{"date":"2021-12-31","value":-3247435800,"profit":false},{"date":"2022-12-31","value":-1104789500,"profit":false},{"date":"2023-12-31","value":-703387500,"profit":false},{"date":"2024-12-31","value":-1760200000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(9.85M)(32.47M)(11.05M)(7.71M)(17.60M)[{"date":"2020-12-31","value":-985139100,"profit":false},{"date":"2021-12-31","value":-3247435800,"profit":false},{"date":"2022-12-31","value":-1104789500,"profit":false},{"date":"2023-12-31","value":-771067300,"profit":false},{"date":"2024-12-31","value":-1760200000,"profit":false}]
EPS (Diluted)(27.80)(38.60)(6.24)(13.26)(5.32)[{"date":"2020-12-31","value":-2780,"profit":false},{"date":"2021-12-31","value":-3860,"profit":false},{"date":"2022-12-31","value":-624,"profit":false},{"date":"2023-12-31","value":-1326,"profit":false},{"date":"2024-12-31","value":-532,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

TENX
Cash Ratio 40.26
Current Ratio 40.48

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

TENX
ROA (LTM) -26.60%
ROE (LTM) -39.78%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

TENX
Debt Ratio Lower is generally better. Negative is bad. 0.02
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.98

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

TENX
Trailing PE 3.57
Forward PE 0.30
P/S (TTM) 0.00
P/B 0.23
Price/FCF NM
EV/R 0.00
EV/Ebitda NM
PEG NM

FAQs

What is Tenax Therapeutics Inc share price today?

Tenax Therapeutics Inc (TENX) share price today is $6.15

Can Indians buy Tenax Therapeutics Inc shares?

Yes, Indians can buy shares of Tenax Therapeutics Inc (TENX) on Vested. To buy Tenax Therapeutics Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TENX stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Tenax Therapeutics Inc be purchased?

Yes, you can purchase fractional shares of Tenax Therapeutics Inc (TENX) via the Vested app. You can start investing in Tenax Therapeutics Inc (TENX) with a minimum investment of $1.

How to invest in Tenax Therapeutics Inc shares from India?

You can invest in shares of Tenax Therapeutics Inc (TENX) via Vested in three simple steps:

  • Click on Sign Up or Invest in TENX stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Tenax Therapeutics Inc shares
What is Tenax Therapeutics Inc 52-week high and low stock price?

The 52-week high price of Tenax Therapeutics Inc (TENX) is $7.89. The 52-week low price of Tenax Therapeutics Inc (TENX) is $2.77.

What is Tenax Therapeutics Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Tenax Therapeutics Inc (TENX) is 3.5706

What is Tenax Therapeutics Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Tenax Therapeutics Inc (TENX) is 0.23

What is the Market Cap of Tenax Therapeutics Inc?

The market capitalization of Tenax Therapeutics Inc (TENX) is $25.51M

What is Tenax Therapeutics Inc’s stock symbol?

The stock symbol (or ticker) of Tenax Therapeutics Inc is TENX

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top